SPOTLIGHT -
Slideshow
Author(s):
A rare but serious reaction to this treatment can have immunological consequences. As with all medications, however, the latest alert does not change how psychiatrists manage the risks.
Diagnosis in Bipolar Disorder: Dealing With Comorbidity
Blue Light, Depression, and Bipolar Disorder
April in Review: Updates on the Psychiatric Treatment Pipeline
Four Myths About Lamotrigine
Online Survey Reveals Clinicians’ Top Concerns in BDI, Schizophrenia Treatment
New NDA Submitted: Bysanti to Treat Acute Bipolar I and Schizophrenia